CompletedPhase 2

Treatment for Calcium Phosphate Kidney Stone Disease

United States13 participantsStarted 2012-07

Plain-language summary

The investigators will examine in two studies whether citric acid or potassium citrate can reduce calcium phosphate saturation in urine of Calcium Phosphate stone formers.

Who can participate

Age range21 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Aim 1 * Hypocitraturic CaP stone formers * urine citrate \<320mg/d * elevated pH as 24-hr urine pH above 6.40 * \>21 years Aim 2 * Hypercalciuric CaP stone formers * 24hr urine calcium \>250mg/d in women and \>300mg/d in men prior to indapamide use * high pH as \>6.40 in the absence of urinary tract infection * \>21 years

What they're measuring

Urinary Calcium Phosphate Saturation

Timeframe: 2 weeks

Trial details

NCT IDNCT01754779

SponsorUniversity of Texas Southwestern Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-02-16

Results submitted2024-01-23

View on ClinicalTrials.gov More Calcium Phosphate Kidney Stones trials